呼吸窘迫病因很多，包括肺炎、急性呼吸窘迫综合症、肺栓塞和慢性阻塞性肺部疾病等。
Etiologies of respiratory distress are numerous and include pneumonia, acute respiratory distress syndrome, pulmonary embolism, and exacerbations of chronic obstructive lung disease.
目的评价肺表面活性物质 （PS）替代治疗新生儿呼吸窘迫综合症 （NRDS ）的疗效及安全性。
Objective To evaluate the efficacy and safety of pulmonary surfactant(PS)in the replacement therapy for neonatal respiratory distress syndrome(NRDS).
目的评价肺表面活性物质 （PS）替代治疗新生儿呼吸窘迫综合症 （NRDS ）的疗效及安全性。
Objective To evaluate the efficacy and safety of pulmonary surfactant(PS)in the replacement therapy for neonatal respiratory distress syndrome(NRDS).
应用推荐